Osteochondral Allograft Effective in Some Knee Cartilage Repair
No abstract available (Source: Lippincott's Bone and Joint Newsletter)
Source: Lippincott's Bone and Joint Newsletter - June 15, 2018 Category: Orthopaedics Tags: Snapshot Source Type: news
Pediatric Kidney Recipients Often Have Subclinical Inflammation
FRIDAY, June 15, 2018 -- For pediatric kidney recipients, subclinical inflammation is associated with increased risk for acute rejection and allograft failure, according to a study published online May 15 in the American Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 15, 2018 Category: Pharmaceuticals Source Type: news
Wright Medical wins FDA PMA for Augment injectable bone graft
Wright Medical (NSDQ:WMGI) said today it won FDA premarket approval for its Augment injectable bone graft.
The bone graft won clearance for the same indications as the Amsterdam-based company’s non-injectable Augment bone graft.
The newly cleared Augment Injectable consists of both recombinant human platelet derived growth factor and a blend of Type I collagen and beta tri-calcium phosphate, the company said.
“In Canada, my colleagues and I have been using Augment Injectable since 2011 based upon its ideal handling characteristics and impressive clinical results. FDA approval of Augment injectable provide...
Source: Mass Device - June 13, 2018 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Orthopedics Pre-Market Approval (PMA) Regulatory/Compliance wrightmedical Source Type: news
NuVasive launches AttraX scaffold bone graft biologic
NuVasive (NSDQ:NUVA) said today it launched its AttraX scaffold ceramic-collagen bone graft in the US, touting that the scaffold’s surface has been shown to increase bone formation for faster fusion than standard ceramic bone grafts.
The San Diego-based company claims that the Attrax scaffold features a unique microstructure and microporosity that are optimized for bone formation, and that its AttraX surface technology drives the differentiation of mesenchymal stem cells into bone-forming osteoblasts without the need for added growth factors.
“AttraX scaffold was easy to use and maintained excellent handling c...
Source: Mass Device - June 12, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Spinal Nuvasive Source Type: news
MiMedx Announces Executive to Lead its International Operations and Provides Update on Company's International Progress
MARIETTA, Ga., June 7, 2018 -- (Healthcare Sales & Marketing Network) -- MiMedx Group, Inc. (NASDAQ: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, today announced that John D. Harris has joined the Company as its Senio... Biopharmaceuticals, Regenerative Medicine, Personnel MiMedx Group, PURION, placental tissue, allograft (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 7, 2018 Category: Pharmaceuticals Source Type: news
Camber Spine wins FDA nod for combining existing tech
Camber Spine Technologies has won 510(k) clearance from the FDA to market its ENZA-A Titanium Anterior Lumbar Interbody Fusion (ALIF) system, which leverages two of its existing technologies.
The new device borrows from the Wayne, Penn.-based company’s first-generation ENZA, which has dual-grip anchor technology, and from its Spira line, which use spiral support arches to increase fusion rates and stabilization. The FDA approved the original Spira device in August 2017.
ENZA-A is indicated for use with autogenous bone graft in patients with degenerative disc disease at one or two contiguous levels from L2 to S1 and is is...
Source: Mass Device - June 4, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: 510(k) Food & Drug Administration (FDA) Regulatory/Compliance Spinal camberspine Source Type: news
7 medtech stories we missed this week: May 25, 2018
[Image from unsplash.com]From Mauna Kea receiving FDA clearance to Medacta getting clearance for its pedicle screw placement guide, here are seven medtech stories we missed this week but thought were still worth mentioning.
1. Mauna Kea wins FDA nod for neurosurgery indication
Mauna Kea announced in a May 24 press release that it has received FDA 510(k) clearance for its Celivizio 100 series F400 and F800 with new Confocal Miniprobe, the CranioFlex. The clearance allows the device to be used during neurosurgical procedures. The Cellvizio 100 with CranioFlex gives allows for imaging of tissue internal microstructures and a...
Source: Mass Device - May 25, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Catheters Diagnostics Food & Drug Administration (FDA) Imaging Implants Patient Monitoring Regulatory/Compliance Bonesupport collagenmatrix crossroadsextremitysystems Implanet Mauna Kea Technologies MC10 Medacta xablec Source Type: news
How Orthopedics Innovation Doesn ’t Get Lost In Shuffle
What are some of the growing trends and unmet needs in the orthopedics market? If you’re a surgeon, just how do you convince the CEO of a hospital to invest in these technologies?
During MDM East, held in New York from June 12-14, Michael Levy, MD will be a part of two panels that will touch on some of these subjects. The panels are titled “Prominent Physicians Address Unmet Needs in Orthopedics” and “Selling Your Idea to Upper Management.”
Levy is an expert in the field and has been involved in orthopedics for 34 years including basic research, orthopedic product development, and clinical practice. He is Boar...
Source: MDDI - May 24, 2018 Category: Medical Devices Authors: Omar Ford Tags: Orthopedics Source Type: news
FDA clears Zimmer Biomet ’ s 3D-printed titanium Zyston spinal implant
Zimmer Biomet (NYSE:ZBH) said yesterday it won FDA 510(k) clearance for its Zyston Strut open titanium interbody spacer system, touting it as the company’s first 3D-printed titanium spinal implant.
The Zyston Strut open titanium system is a family of lumbar cages intended to enhance strength, graft capacity and visualization capabilities of interbody spacers in spinal fusion cases, the Warsaw, Ind.-based company said. The system also includes surgical instruments needed for insertion, manipulation and removal.
The newly cleared cages will be available in a series of sizes to accommodate different patient anatomies a...
Source: Mass Device - May 23, 2018 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Regulatory/Compliance Spinal zimmerbiomet Source Type: news
Therapies After Autograft Failure in a Patient With Melanoma Therapies After Autograft Failure in a Patient With Melanoma
This report describes a case of amelanotic melanoma of the foot initially diagnosed and treated as a pressure ulcer.Wounds (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 23, 2018 Category: Consumer Health News Tags: General Surgery Journal Article Source Type: news
Does anterior cruciate ligament reconstruction affect the outcome of osteochondral allograft transplantation? A matched cohort study with a mean follow-up of 6 years - T írico LEP, McCauley JC, Pulido PA, Bugbee WD.
BACKGROUND: Few studies have evaluated the influence of anterior cruciate ligament (ACL) reconstruction on the outcome of cartilage repair. Hypothesis/Purpose: The purpose was to investigate the association between ACL reconstruction and functional outcome... (Source: SafetyLit)
Source: SafetyLit - May 21, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
Medtronic wins expanded indications for Infuse bone growth protein
Medtronic (NYSE:MDT) said today it won expanded approval from the FDA for its Infuse bone growth protein implant, marking the second expansion for the implant over the past two years.
The Infuse implant contains the active ingredient rhBMP-2, a manufactured version of a bone growth protein normally present in the body. The Infuse device is designed for use with certain Medtronic interbody fusion devices to treat lumbar degenerative disc disease.
“Different spine patients can have very different surgical needs, so the more options surgeons have to combine a clinically-proven bone grafting technology like Infuse with d...
Source: Mass Device - April 30, 2018 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Regulatory/Compliance Spinal Medtronic Source Type: news
Newly Founded Company, Datum Orthobiologics, to Apply Dental Technology in Orthopedics
Collagen Technology Mimics Nature, to Regenerate Bone and Cartilage
NESS ZIONA, Israel, April 24, 2018 -- (Healthcare Sales & Marketing Network) -- Datum Biotech Ltd. has announced the founding of Datum Orthobiologics Ltd. Datum Orthobiologics will foc... Devices, Orthopaedic, Regenerative Medicine Datum Biotech, Datum Orthobiologics, bone graft, GLYMATRIX (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 24, 2018 Category: Pharmaceuticals Source Type: news
Infected tooth with sinus perforation treatment: feedback?
A middle aged woman presented with a swollen gingiva buccal to tooth #15 which had a previous RCT and crown. I am wondering if I should place a membrane and bone graft after extracting the tooth or if I should let it drain on its own?The postInfected tooth with sinus perforation treatment: feedback? appeared first onOsseoNews Dental Implants. (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - April 17, 2018 Category: Dentistry Authors: osseonews Tags: Clinical Cases Regenerative Surgical Source Type: news
Spineology touts 1-year OptiMesh lumbar interbody fusion study results
Spinal tech developer Spineology today released 12-month results from a study of its OptiMesh deployable implant designed for use in instrumented lumbar interbody fusion procedures to treat degenerative disc disease.
Results from the Scout trial were presented at the annual meeting of the International Society for the Advancement of Spine Surgery in Toronto, the St. Paul, Minn.-based company said.
“We are grateful to Dr. Chi and all the Scout investigators for their dedication in helping us to complete this important clinical trial. We look forward to completing the patient follow-up and gaining the market clearanc...
Source: Mass Device - April 12, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Spinal Spineology Source Type: news
